Uncovering Value In R&D Tax Credit Processes Through Strategic IP Management.svg?width=700&auto=webp&quality=80&disable=upscale)
R&DUncovering Value In R&D Tax Credit Processes Through Strategic IP ManagementUncovering Value In R&D Tax Credit Processes Through Strategic IP Management
Medical device manufacturers in the United States, Europe, and Canada are capitalizing on government incentives designed to encourage research and development. Most such incentives come through tax-based programs. These programs return a portion of the costs associated with qualified R&D activities to companies in the form of tax credits. Companies pursuing the tax credits must engage in a vigorous application process that requires thorough documentation of R&D activities and their related expenditures.
Sign up for the QMED & MD+DI Daily newsletter.